Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

ClinicalTrials.gov ID: NCT00000940

Public ClinicalTrials.gov record NCT00000940. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion

Study identification

NCT ID
NCT00000940
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
121 participants

Conditions and interventions

Conditions

Interventions

  • Ritonavir Drug
  • Abacavir sulfate Drug
  • Amprenavir Drug
  • Lamivudine Drug
  • Stavudine Drug

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 1999
Primary completion
Not listed
Completion
Sep 30, 2006
Last update posted
Oct 28, 2021

1999 – 2006

United States locations

U.S. sites
18
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
USC CRS Los Angeles California 90033
UCLA CARE Center CRS Los Angeles California 90035
Ucsd, Avrc Crs San Diego California 92103
Ucsf Aids Crs San Francisco California 94110
University of Colorado Hospital CRS Aurora Colorado 80045
Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu Hawaii 96816
Massachusetts General Hospital ACTG CRS Boston Massachusetts 02114
SSTAR, Family Healthcare Ctr. Fall River Massachusetts 02720
Washington U CRS St Louis Missouri 63110
Beth Israel Med. Ctr. ACTU New York New York 10003
NY Univ. HIV/AIDS CRS New York New York 10016
Columbia P&S CRS New York New York 10032
AIDS Care CRS Rochester New York 14607
McCree McCuller Wellness Ctr. at the Connection, Infectious Disease Unit Rochester New York 14642
Univ. of Rochester ACTG CRS Rochester New York 14642
Unc Aids Crs Chapel Hill North Carolina 27514
Hosp. of the Univ. of Pennsylvania CRS Philadelphia Pennsylvania 19104
The Miriam Hosp. ACTG CRS Providence Rhode Island 02906

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000940, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000940 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →